All Stories

  1. Circulatory dietary and gut-derived metabolites predict early cognitive decline
  2. Brief, repeated isoflurane anaesthesia elicits sex-dependent behavioural, cerebrovascular, and microglial alterations in mice
  3. A novel Mediterranean diet-inspired supplement reduces hippocampal amyloid deposits and microglial activation through the modulation of the microbiota gut-brain axis in 5xFAD mice
  4. Building a roadmap to nutrition for Healthy Ageing: a brief report on the ILSI Europe Healthy Ageing Task Force
  5. A standardised saffron extract improves subjective and objective sleep quality in healthy older adults with sleep complaints: results from the Gut-Sleep-Brain Axis randomised, double-blind, placebo-controlled pilot study
  6. Dietary substances and their glucuronides: structures, occurrence and biological activity
  7. Dietary (Poly)phenols and the Gut–Brain Axis in Ageing
  8. Stimulation of the Pro-Resolving Receptor Fpr2 Reverses Inflammatory Microglial Activity by Suppressing NFκB Activity
  9. Regulation of Physiological Barrier Function by the Commensal Microbiota
  10. Promiscuous Receptors and Neuroinflammation: The Formyl Peptide Class
  11. A host–gut microbial amino acid co-metabolite, p-cresol glucuronide, promotes blood–brain barrier integrity in vivo
  12. A host–gut microbial co-metabolite of aromatic amino acids, p-cresol glucuronide, promotes blood–brain barrier integrity in vivo
  13. Impact of metabolic disorders on the structural, functional, and immunological integrity of the blood‐brain barrier: Therapeutic avenues
  14. Regulation of blood–brain barrier integrity by microbiome-associated methylamines and cognition by trimethylamine N-oxide
  15. Exploiting formyl peptide receptor 2 to promote microglial resolution: a new approach to Alzheimer’s disease treatment
  16. Analysis of circulating protein aggregates as a route of investigation into neurodegenerative disorders
  17. Activation of the pro-resolving receptors Fpr2/3 attenuate lipopolysaccharide-induced inflammatory microglial activation
  18. Reversal of β-Amyloid-Induced Microglial Toxicity In Vitro by Activation of Fpr2/3
  19. Immuno-metabolic impact of the multiple sclerosis patients’ sera on endothelial cells of the blood-brain barrier
  20. Analysis of circulating protein aggregates reveals pathological hallmarks of amyotrophic lateral sclerosis
  21. Reversal of β-amyloid induced microglial toxicity in vitro by activation of Fpr2/3
  22. Annexin A1 drives macrophage skewing to accelerate muscle regeneration through AMPK activation
  23. Modeling Cardiac Dysfunction Following Traumatic Hemorrhage Injury: Impact on Myocardial Integrity
  24. Desmoglein-3 acts as a pro-survival protein by suppressing reactive oxygen species and doming whilst augmenting the tight junctions in MDCK cells
  25. Estrogen Promotes Pro-resolving Microglial Behavior and Phagocytic Cell Clearance Through the Actions of Annexin A1
  26. Estrogen promotes pro-resolving microglial behaviour and phagocytic cell clearance through the actions of annexin A1:
  27. Activin subfamily peptides predict chronological age in humans
  28. Microbiome–host systems interactions: protective effects of propionate upon the blood–brain barrier
  29. A chemical produced by gut bacteria can help protect the blood–brain barrier
  30. The restorative role of annexin A1 at the blood–brain barrier
  31. Counteractive effects of antenatal glucocorticoid treatment on D1 receptor modulation of spatial working memory
  32. Estrogen protects the blood–brain barrier from inflammation-induced disruption and increased lymphocyte trafficking
  33. Definition of a Novel Pathway Centered on Lysophosphatidic Acid To Recruit Monocytes during the Resolution Phase of Tissue Inflammation
  34. Sex-specific disruption of murine midbrain astrocytic and dopaminergic developmental trajectories following antenatal GC treatment
  35. Astroglial Plasticity Is Implicated in Hippocampal Remodelling in Adult Rats Exposed to Antenatal Dexamethasone
  36. Nonredundant protective properties of FPR2/ALX in polymicrobial murine sepsis
  37. Sex-dependent diversity in ventral tegmental dopaminergic neurons and developmental programing: A molecular, cellular and behavioral analysis
  38. Identification of a Novel Recycling Sequence in the C-tail of FPR2/ALX Receptor
  39. Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice
  40. Ligand-specific conformational change of the G-protein–coupled receptor ALX/FPR2 determines proresolving functional responses
  41. Chemerin15 inhibits neutrophil-mediated vascular inflammation and myocardial ischemia-reperfusion injury through ChemR23
  42. Antenatal Glucocorticoid Treatment Induces Adaptations in Adult Midbrain Dopamine Neurons, which Underpin Sexually Dimorphic Behavioral Resilience
  43. Oestrogen and immunomodulation: new mechanisms that impact on peripheral and central immunity
  44. Prazosin, an α1-adrenoceptor antagonist, prevents memory deterioration in the APP23 transgenic mouse model of Alzheimer's disease
  45. Identification of an essential endogenous regulator of blood–brain barrier integrity, and its pathological and therapeutic implications
  46. Annexin A1 N-Terminal Derived Peptide Ac2-26 Exerts Chemokinetic Effects on Human Neutrophils
  47. Novel Ontogenetic Patterns of Sexual Differentiation in Arcuate Nucleus GHRH Neurons Revealed in GHRH-Enhanced Green Fluorescent Protein Transgenic Mice
  48. Peripheral vs. Central Sex Steroid Hormones in Experimental Parkinson?s Disease
  49. Annexin A1: A Central Player in the Anti-Inflammatory and Neuroprotective Role of Microglia
  50. Anti-allergic drugs and the Annexin-A1 system
  51. Estrogen Actions in the Brain and the Basis for Differential Action in Men and Women: A Case for Sex-Specific Medicines
  52. Independent influences of sex steroids of systemic and central origin in a rat model of Parkinson's disease: A contribution to sex-specific neuroprotection by estrogens
  53. Annexin A1 regulates hormone exocytosis through a mechanism involving actin reorganization
  54. Cromoglycate drugs suppress eicosanoid generation in U937 cells by promoting the release of Anx-A1
  55. Annexin A1 in the brain – undiscovered roles?
  56. Striatal susceptibility to a dopaminergic neurotoxin is independent of sex hormone effects on cell survival and DAT expression but is exacerbated by central aromatase inhibition
  57. The Size and Distribution of Midbrain Dopaminergic Populations are Permanently Altered by Perinatal Glucocorticoid Exposure in a Sex- Region- and Time-Specific Manner
  58. Perinatal Glucocorticoid Treatment Disrupts the Hypothalamo-Lactotroph Axis in Adult Female, But Not Male, Rats
  59. Altered Mesencephalic Dopaminergic Populations in Adulthood as a Consequence of Brief Perinatal Glucocorticoid Exposure
  60. Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease
  61. Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females